Search

everythinglearnresearchcommunity

for

Search:↓

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Alopecia areata patients have higher risks of infections, lymphoma, heart issues, and death.

Certain genetic variants increase the risk of aggressive prostate cancer.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Hair keratin treatments can be harmful, potentially causing health issues like skin reactions and cancer.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Ultrasound-based radiomics and radiogenomics can improve ovarian cancer diagnosis and treatment, but need better standardization and AI tools.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Men and women may have different risks of getting skin cancer.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Most skin tumors in the study were benign, with squamous cell carcinoma being the most common malignant type.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Acne is the most common skin problem in Brazil, with a need for improved dermatological care and health education, especially for the public sector and black-skinned individuals.